×

Real-time individual predictions of prostate cancer recurrence using joint models. (English) Zbl 1272.62093

Summary: Patients who were previously treated for prostate cancer with radiation therapy are monitored at regular intervals using a laboratory test called prostate specific antigen (PSA). If the value of the PSA test starts to rise, this is an indication that the prostate cancer is more likely to recur, and the patient may wish to initiate new treatments. Such patients could be helped in making medical decisions by an accurate estimate of the probability of recurrence of the cancer in the next few years. In this article, we describe the methodology for giving the probability of recurrence for a new patient, as implemented on a web-based calculator. The methods use a joint longitudinal survival model. The model is developed on a training dataset of 2386 patients and tested on a dataset of 846 patients. Bayesian estimation methods are used with one Markov chain Monte Carlo (MCMC) algorithm developed for estimation of the parameters from the training dataset and a second quick MCMC developed for prediction of the risk of recurrence that uses the longitudinal PSA measures from a new patient.

MSC:

62P10 Applications of statistics to biology and medical sciences; meta analysis
PDFBibTeX XMLCite
Full Text: DOI Link

References:

[1] Ankerst, Handbook of Statistics in Clinical Oncology pp 397– (2006) · Zbl 1140.62347
[2] Henderson, Joint modelling of longitudinal measurements and event time data, Biostatistics 1 pp 465– (2000) · Zbl 1089.62519 · doi:10.1093/biostatistics/1.4.465
[3] Kennedy, The effect of salvage therapy on survival in a longitudinal study with treatment by indication, Statistics in Medicine 29 pp 2569– (2010) · doi:10.1002/sim.4017
[4] Lin, Latent class models for joint analysis of longitudinal biomarker and event process data, Journal of the American Statistical Association 97 pp 53– (2002) · Zbl 1073.62582 · doi:10.1198/016214502753479220
[5] Pickles, Evaluation of the Houston biochemical relapse definition in men treated with prolonged neoadjuvant and adjuvant androgen ablation and assessment of follow-up lead-time bias, International Journal of Radiation Oncology, Biology, Physics 57 pp 11– (2003) · doi:10.1016/S0360-3016(03)00439-5
[6] Proust-Lima, Joint latent class models for longitudinal and time-to-event data: A review, Statistical Methods in Medical Research (2012)
[7] Proust-Lima, Development and validation of a dynamic prognostic tool for prostate cancer recurrence using repeated measures of posttreatment PSA: A joint modeling approach, Biostatistics 10 pp 535– (2009) · doi:10.1093/biostatistics/kxp009
[8] Proust-Lima, Determinants of change in prostate-specific antigen over time and its association with recurrence after external beam radiation therapy for prostate cancer in five large cohorts, International Journal of Radiation Oncology, Biology, Physics 72 pp 782– (2008) · doi:10.1016/j.ijrobp.2008.01.056
[9] Rizopoulos, Dynamic predictions and prospective accuracy in joint models for longitudinal and time-to-event data, Biometrics 67 pp 819– (2011) · Zbl 1226.62124 · doi:10.1111/j.1541-0420.2010.01546.x
[10] Roach, Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference, International Journal of Radiation Oncology, Biology, Physics 65 pp 965– (2006) · doi:10.1016/j.ijrobp.2006.04.029
[11] Steyerberg, Assessing the performance of prediction models: A framework for traditional and novel measures, Epidemiology 21 pp 128– (2010) · doi:10.1097/EDE.0b013e3181c30fb2
[12] Taylor, Validation of biomarker-based risk prediction models, Clinical Cancer Research 14 pp 5977– (2008) · doi:10.1158/1078-0432.CCR-07-4534
[13] Taylor, Individualized predictions of disease progression following radiation therapy for prostate cancer, Journal of Clinical Oncology 23 pp 816– (2005) · doi:10.1200/JCO.2005.12.156
[14] Wang, Jointly modeling longitudinal and event time data with application to acquired immunodeficiency syndrome, Journal of the American Statistical Association 96 pp 895– (2001) · Zbl 1047.62115 · doi:10.1198/016214501753208591
[15] Xu, Joint analysis of longitudinal data comprising repeated measures and times to events, Journal of the Royal Statistical Society. Series C (Applied Statistics) 50 pp 375– (2001) · Zbl 1112.62312 · doi:10.1111/1467-9876.00241
[16] Yu, Joint longitudinal-survival-cure models and their application to prostate cancer, Statistica Sinica 14 pp 835– (2004) · Zbl 1073.62111
[17] Yu, Individual prediction in prostate cancer studies using a joint longitudinal survival-cure model, Journal of the American Statistical Association 103 pp 178– (2008) · Zbl 1469.62383 · doi:10.1198/016214507000000400
This reference list is based on information provided by the publisher or from digital mathematics libraries. Its items are heuristically matched to zbMATH identifiers and may contain data conversion errors. In some cases that data have been complemented/enhanced by data from zbMATH Open. This attempts to reflect the references listed in the original paper as accurately as possible without claiming completeness or a perfect matching.